Primary Care Update 2024
December 11-13 2024
More ...
“I am thankful that she told us about the latest guidelines that were updated 2 days ago.
This was a really good presentation. It made me realize I need to brush up on my CKD knowledge, especially in the setting of anemia and Bone-Mineral Density.
The presenter was knowledgeable and displayed her expertise in the practice setting”
-
1. Discuss the mechanisms of action, role and pros/cons of SGLT2-inhibitors and finerenone in the prevention of CKD progression.
2. Discuss the mechanisms of action, pharmacokinetic, and pharmacodynamic characteristics of loop and thiazide diuretic agents.
3. Describe the mechanisms of action and pros/cons of therapies for the management of hyperkalemia, anemia, and CKD-MBD.
4. Choose an appropriate management for edema, acute and chronic hyperkalemia, anemia, and CKD-MDB in a patient with CKD.
5. Discuss the mechanisms of action, role and pros/cons of current and emerging therapies for the treatment of IgA Nephropathy.
-
Discuss the burden of opioid misuse and abuse on the individual and society.
2. Describe the funda- mental concepts of pain management, including: a) addiction; b) tolerance; c) dependency; d) hyperalgesia; e) allodynia.
3. State key principles for assessing patients in pain, identifying risk factors and behaviors that are associated with opioid misuse, abuse, and addiction.
4. Describe the similarities and differences in the mechanism of action for opioids, cannabinoids and gabapentenoids.
5. Compare and contrast the benefits, risks and role of opioids, cannabinoids and gabapentenoids in managing pain.
6. Describe the best practice model for properly monitoring patients who are started on opioids, gabapentenoids and cannabinoids to minimize the risks of adverse reactions, over-dosage and inappropriate compliance.
7. Compare and contrast the following product formulations of gabapentenoids with respect to their benefits and risks in managing pain: a) gabapentin (Neurontin); b) Horizant; c) Gralise; and, d) Lyrica.
8. Compare and contrast the most common cannabinoids found in marijuana with regards to their benefits and risks in managing pain and other symptoms.
9. State the risks of combining opioids with: a) benzodiazepines; b) alcohol; c) gabapentenoids; and d) cannabinoids.
10. Describe how to counsel patients and caregivers regarding the safe use on naloxone for opioid overdose
-
Protecting the Vulnerable: Improving Safety of Antimicrobials in the Elderly Population:
1. Evaluate methods to improve safety of antimicrobial prescribing in the elderly.
2. Review antimicrobial therapy recommendations within Beers Criteria.
3. Examine best antimicrobials practices through case application.
Mastering Migraine Management: Update on Current Therapies:
4. Review current older management strategies for migraine headaches.
5. Discuss role of newer agents including CGRP inhibitors.
6. Examine best practices through case application.
Obesity and Weight Loss:
7. Review risk factors and criteria within obesity
8. Describe appropriate patient populations for weight loss pharmacotherapy.
9. Delineate key characteristics of various approved and future pharmacotherapy options including GLP-1 and GIP agonists.
10. Apply knowledge within patient cases to select an appropriate pharmacotherapy option.
“A pleasure. Dr was so informative and without bias able to clearly show pathways to treatment of pain and it’s management. I took away so many clinical pearls
EXCELLENT instructor! The information he provided will help me in my daily practice. Thank you!!!
I found this talk very interesting!! Helped with my confidence in prescribing opiates and gabapentinoids
Even over Zoom he kept me engaged and interested in the subject matter (which can be dry) and I actually learned quite a bit.
I do see patients who are already on various pain medications including opioids and I feel much more empowered to help them navigate options and look for interactions and warning signs. ”
“Great speaker. He NEVER read from a slide, he knew what he was talking about and it showed. (have attended CME and all the speaker did was read from slides) He had a down to earth presentation that kept my interest the whole time. Very satisfied!
Great program so informative and what a great approach to pain management. Lots of clinical pearls I will use. A pleasure
Great content, very applicable to my practice. best speaker in 3 day course, will be looking for other lectures from him.
I thoroughly enjoyed this instructor. I’m going to follow him on instagram. He was great”
View sample from day 3 part 3.
About This Course
This on demand course was recorded live in Westgate Resort and Casino where Las Vegason Decmber 11-13 2024. It provides 15 hours. live AAFP/ AMA PRA Category 1 Credit™, ACPE and pharmacology CE/ CME credit.
Price $299
-
Dr. Sheryl (Follin) Vondracek, Pharm.D., FCCP, BCPS
Dr. Sheryl (Follin) Vondracek, Pharm.D., FCCP, BCPS
Board Certified Pharmacotherapy Specialist, Associate Professor, Department of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado
-
Dr. Joseph Saseen, Pharm.D., FASHP, FCCP, BCPS, BCACP
Joseph Saseen is Associate Dean for Clinical Affairs and Professor of Clinical Pharmacy and a Professor of Family Medicine. He also served as Vice Chair of the Department of Clinical Pharmacy for 10 years. Dr. Saseen has responsibilities for enhancing the school’s clinical enterprise, further developing sustainable clinical service models, and advocating for advancing the practice of pharmacy in the State of Colorado. His scholarly work includes almost 200 peer-reviewed publications and book chapters.
-
Dr. Gregory L. Holmquist, PharmD, CPE
Dr. Holmquist received his undergraduate and graduate degrees from the School of Pharmacy at the University of Washington in Seattle. He is a board certified Oncology Pharmacist, an American Medical Association Certified Educator for Physicians on Endof-Life Care, and an American Society of Pain Educators Certified Pain Educator (C.P.E.). As a clinician and educator, Dr. Holmquist’s philosophy of care is summarized in one core statement, “Making a difference in the lives of patients”
TARGET AUDIENCE/ ACCREDITATION
PHARMACISTS: University Learning Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. These programs are accredited for pharmacists.
NURSE PRACTITIONERS/ NURSES: This course provides 15 contact hours (1.5 CEU) over three days, 5 hours per day, to fulfill the pharmacotherapeutics/ pharmacology requirements for American Nurses Credentialing Center (ANCC) Category 1 Continuing Education Hours for certification renewal. The same hours submitted to renew certification may be submitted to a State Board of Nursing for re-licensure. American Nurses Credentialing Center (ANCC) accepts formally approved continuing education sponsored by organizations accredited or approved by the Accreditation Council for Pharmacy Education (ACPE). .
PHYSICIANS: The AAFP has reviewed Current Treatment Strategies 2024 and deemed it acceptable for up to 15.00 Live AAFP Prescribed credit(s). Term of Approval is from 12/11/2024 to 12/13/2027. Physicians should claim only the credit commensurate with the extent of their participation in the activity. AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 Credit™ toward the AMA Physician’s Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1. CME programs approved by the AAFP are eligible for Category 2 credit (or Category 1-A under special circumstances) through the American Osteopathic Association (AOA).
PHYSICIAN ASSISTANTS: American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for Prescribed credit from AAFP. Physician assistants may report the number of hours stated above of Category I credit for completing this program.
CONSULTANT PHARMACISTS: Some consultant pharmacist boards accept University Learning Systems courses for recertification either as is or with board approval. Please contact your board regarding course approval and ULS with any questions.
CANADIAN PHARMACISTS: Canadian Council on Continuing Education in Pharmacy (CCCEP) accepts courses accredited by the Accreditation Council for Pharmacy Education (ACPE). This credit is applicable to health professionals who may require pharmacology credit.
CANADIAN PHYSICIANS: Members of the College of Family Physicians of Canada are eligible to receive up to 15 MAINPRO-M1 credits for participation in this activity due to reciprocal agreement with the American Academy of Family Physicians.
OTHER HEALTH PROFESSIONALS: Contact your respective board regarding approval.
| Session |
Contact Hours |
ACPE UAN |
Activity |
|
Session 1 |
5 |
0741-0000-24-031-L01-P |
Application |
| Session 2 | 5 | 0741-0000-24-032-L01-P | Application |
| Session 3 | 5 | 0741-0000-24-033-L01-P | Application |